SCHEMBL12166370

SCHEMBL12166370

CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc(F)c4)nc(N)c3s2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 16/20 0.59
PIK3CD O00329 10/20 0.59
PIK3CB P42338 10/20 0.59
PIK3CG P48736 9/20 0.59
MTOR P42345 6/20 0.56
ADORA2A P29274 1/20 0.52
ADORA1 P30542 1/20 0.52
PIK3R1 P27986 2/20 0.48
PIK3C2A O00443 1/20 0.47
PLK4 O00444 1/20 0.47
PIK3R2 O00459 1/20 0.47
PIK3C2B O00750 1/20 0.47
GAK O14976 1/20 0.47
EPHB6 O15197 1/20 0.47
DAPK3 O43293 1/20 0.47
STK16 O75716 1/20 0.47
PIK3C2G O75747 1/20 0.47
NTRK1 P04629 1/20 0.47
NQO2 P16083 1/20 0.47
CSNK2A2 P19784 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2738865 0.85 PIK3CA (0.82) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL12807329 0.78 PIK3CA (0.76) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL190202 0.75 PIK3CA (0.80) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL962660 0.74 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL191051 0.74 PIK3CD (0.81) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
Methanesulfonamide SCHEMBL2574939 0.74 PIK3CA (0.95) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL189657 0.74 PIK3CA (0.82) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL190172 0.73 PIK3CA (0.84) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL190409 0.73 PIK3CA (1.00) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL12166180 0.73 PIK3CA (0.69) PIK3CAPIK3CDPIK3CBPIK3CGMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2041139-B1 PHARMACEUTICAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2011-11-09 EP disclosed